[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Meningococcal Infections Vaccine Market Report 2016

December 2016 | 104 pages | ID: U3AEF85E511EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Meningococcal Infections Vaccine

Revenue, means the sales value of Meningococcal Infections Vaccine

This report studies sales (consumption) of Meningococcal Infections Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Sanofi-Pasteur
  • Beijing Tiantan Biological Products
  • Shanghai Institute of Biological Products
  • Wuhan Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Hualan Biological Engineering
  • Chongqing Zhifei Biological Products
  • Zhejiang Tianyuan Bio-Pharmaceutical
  • Walvax Biotechnology
  • Royal(Wuxi) Bio-Pharmaceutical
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Meningococcal Infections Vaccine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Meningococcal Infections Vaccine Market Report 2016

1 MENINGOCOCCAL INFECTIONS VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Meningococcal Infections Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meningococcal Infections Vaccine (2011-2021)
  1.4.1 United States Meningococcal Infections Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Meningococcal Infections Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Meningococcal Infections Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meningococcal Infections Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meningococcal Infections Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Meningococcal Infections Vaccine Market Competitive Situation and Trends
  2.4.1 Meningococcal Infections Vaccine Market Concentration Rate
  2.4.2 Meningococcal Infections Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Meningococcal Infections Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Meningococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Meningococcal Infections Vaccine Price by Type (2011-2016)
3.4 United States Meningococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Meningococcal Infections Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Meningococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Sanofi-Pasteur
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Beijing Tiantan Biological Products
  5.2.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Shanghai Institute of Biological Products
  5.3.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Wuhan Institute of Biological Products
  5.4.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Lanzhou Institute of Biological Products
  5.5.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Hualan Biological Engineering
  5.6.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Chongqing Zhifei Biological Products
  5.7.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Zhejiang Tianyuan Bio-Pharmaceutical
  5.8.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Walvax Biotechnology
  5.9.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Royal(Wuxi) Bio-Pharmaceutical
  5.10.2 Meningococcal Infections Vaccine Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 MENINGOCOCCAL INFECTIONS VACCINE MANUFACTURING COST ANALYSIS

6.1 Meningococcal Infections Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meningococcal Infections Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meningococcal Infections Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meningococcal Infections Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST (2016-2021)

10.1 United States Meningococcal Infections Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Meningococcal Infections Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Meningococcal Infections Vaccine Sales Forecast by Application (2016-2021)
10.4 Meningococcal Infections Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Infections Vaccine
Table Classification of Meningococcal Infections Vaccine
Figure United States Sales Market Share of Meningococcal Infections Vaccine by Type in 2015
Table Application of Meningococcal Infections Vaccine
Figure United States Sales Market Share of Meningococcal Infections Vaccine by Application in 2015
Figure United States Meningococcal Infections Vaccine Sales and Growth Rate (2011-2021)
Figure United States Meningococcal Infections Vaccine Revenue and Growth Rate (2011-2021)
Table United States Meningococcal Infections Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Meningococcal Infections Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meningococcal Infections Vaccine Sales Share by Manufacturers
Figure 2016 Meningococcal Infections Vaccine Sales Share by Manufacturers
Table United States Meningococcal Infections Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Meningococcal Infections Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Meningococcal Infections Vaccine Revenue Share by Manufacturers
Table 2016 United States Meningococcal Infections Vaccine Revenue Share by Manufacturers
Table United States Market Meningococcal Infections Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Meningococcal Infections Vaccine Average Price of Key Manufacturers in 2015
Figure Meningococcal Infections Vaccine Market Share of Top 3 Manufacturers
Figure Meningococcal Infections Vaccine Market Share of Top 5 Manufacturers
Table United States Meningococcal Infections Vaccine Sales by Type (2011-2016)
Table United States Meningococcal Infections Vaccine Sales Share by Type (2011-2016)
Figure United States Meningococcal Infections Vaccine Sales Market Share by Type in 2015
Table United States Meningococcal Infections Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Meningococcal Infections Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Type (2011-2016)
Table United States Meningococcal Infections Vaccine Price by Type (2011-2016)
Figure United States Meningococcal Infections Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Meningococcal Infections Vaccine Sales by Application (2011-2016)
Table United States Meningococcal Infections Vaccine Sales Market Share by Application (2011-2016)
Figure United States Meningococcal Infections Vaccine Sales Market Share by Application in 2015
Table United States Meningococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Meningococcal Infections Vaccine Sales Growth Rate by Application (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Beijing Tiantan Biological Products Basic Information List
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Shanghai Institute of Biological Products Basic Information List
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Wuhan Institute of Biological Products Basic Information List
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Lanzhou Institute of Biological Products Basic Information List
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Engineering Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Chongqing Zhifei Biological Products Basic Information List
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Zhejiang Tianyuan Bio-Pharmaceutical Basic Information List
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Walvax Biotechnology Basic Information List
Table Walvax Biotechnology Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Walvax Biotechnology Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Royal(Wuxi) Bio-Pharmaceutical Basic Information List
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Infections Vaccine
Figure Manufacturing Process Analysis of Meningococcal Infections Vaccine
Figure Meningococcal Infections Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Infections Vaccine Major Manufacturers in 2015
Table Major Buyers of Meningococcal Infections Vaccine
Table Distributors/Traders List
Figure United States Meningococcal Infections Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Meningococcal Infections Vaccine Production Forecast by Type (2016-2021)
Table United States Meningococcal Infections Vaccine Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories